Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling.

Segal NH, Pavlidis P, Noble WS, Antonescu CR, Viale A, Wesley UV, Busam K, Gallardo H, DeSantis D, Brennan MF, Cordon-Cardo C, Wolchok JD, Houghton AN.

J Clin Oncol. 2003 May 1;21(9):1775-81.

PMID:
12721254
2.

Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.

Schaefer KL, Brachwitz K, Wai DH, Braun Y, Diallo R, Korsching E, Eisenacher M, Voss R, Van Valen F, Baer C, Selle B, Spahn L, Liao SK, Lee KA, Hogendoorn PC, Reifenberger G, Gabbert HE, Poremba C.

Cancer Res. 2004 May 15;64(10):3395-405.

3.

Visceral clear cell sarcoma of soft tissue with confirmation by EWS-ATF1 fusion detection.

Granville L, Hicks J, Popek E, Dishop M, Tatevian N, Lopez-Terrada D.

Ultrastruct Pathol. 2006 Jan-Feb;30(1):111-8.

PMID:
16517477
4.

Establishment of a new continuous clear cell sarcoma cell line. Morphological and cytogenetic characterization and detection of chimaeric EWS/ATF-1 transcripts.

Hiraga H, Nojima T, Abe S, Yamashiro K, Yamawaki S, Kaneda K, Nagashima K.

Virchows Arch. 1997 Jul;431(1):45-51.

PMID:
9247632
5.

Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated Melan-A antigen and overexpressing C-MYC oncogene.

Moritake H, Sugimoto T, Asada Y, Yoshida MA, Maehara Y, Epstein AL, Kuroda H.

Cancer Genet Cytogenet. 2002 May;135(1):48-56.

PMID:
12072203
6.

Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.

Hisaoka M, Ishida T, Kuo TT, Matsuyama A, Imamura T, Nishida K, Kuroda H, Inayama Y, Oshiro H, Kobayashi H, Nakajima T, Fukuda T, Ae K, Hashimoto H.

Am J Surg Pathol. 2008 Mar;32(3):452-60. doi: 10.1097/PAS.0b013e31814b18fb.

PMID:
18300804
7.

Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts).

Langezaal SM, Graadt van Roggen JF, Cleton-Jansen AM, Baelde JJ, Hogendoorn PC.

Br J Cancer. 2001 Feb;84(4):535-8.

8.

Diagnosis of clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin embedded tissues: clinicopathologic and molecular analysis of 44 patients from the French sarcoma group.

Coindre JM, Hostein I, Terrier P, Bouvier-Labit C, Collin F, Michels JJ, Trassard M, Marques B, Ranchere D, Guillou L.

Cancer. 2006 Sep 1;107(5):1055-64.

9.

EWS-ATF1 fusion transcripts in gastrointestinal tumors previously diagnosed as malignant melanoma.

Covinsky M, Gong S, Rajaram V, Perry A, Pfeifer J.

Hum Pathol. 2005 Jan;36(1):74-81.

PMID:
15712185
10.

Diagnostic utility of EWS break-apart fluorescence in situ hybridization in distinguishing between non-cutaneous melanoma and clear cell sarcoma.

Song JS, Choi J, Kim JH, Jang SJ, Cho KJ.

Pathol Int. 2010 Sep;60(9):608-13. doi: 10.1111/j.1440-1827.2010.02570.x.

PMID:
20712646
11.

Clear cell sarcoma or malignant melanoma of soft parts: molecular analysis of microsatellite instability with clinical correlation.

Aue G, Hedges LK, Schwartz HS, Bridge JA, Neff JR, Butler MG.

Cancer Genet Cytogenet. 1998 Aug;105(1):24-8.

PMID:
9689926
12.

Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases.

Antonescu CR, Tschernyavsky SJ, Woodruff JM, Jungbluth AA, Brennan MF, Ladanyi M.

J Mol Diagn. 2002 Feb;4(1):44-52.

13.

Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma.

Patel RM, Downs-Kelly E, Weiss SW, Folpe AL, Tubbs RR, Tuthill RJ, Goldblum JR, Skacel M.

Mod Pathol. 2005 Dec;18(12):1585-90.

14.

Gastrointestinal melanoma or clear cell sarcoma? Molecular evaluation of 7 cases previously diagnosed as malignant melanoma.

Lyle PL, Amato CM, Fitzpatrick JE, Robinson WA.

Am J Surg Pathol. 2008 Jun;32(6):858-66. doi: 10.1097/PAS.0b013e31815b8288.

PMID:
18408594
15.

Clear cell tumors of the somatic soft tissues.

d'Amore ES, Ninfo V.

Semin Diagn Pathol. 1997 Nov;14(4):270-80. Review.

PMID:
9383826
16.

Lessons to be learned: a case study approach. Malignant melanoma of soft tissue.

Dewan M, Malatani TS, Ansari MA.

J R Soc Promot Health. 2005 Jan;125(1):42-6.

PMID:
15712852
17.
18.

Utility of CD117 immunoreactivity in differentiating metastatic melanoma from clear cell sarcoma.

Garcia JJ, Kramer MJ, Mackey ZB, O'Donnell RJ, Horvai AE.

Arch Pathol Lab Med. 2006 Mar;130(3):343-8.

PMID:
16519562
19.

Myxoid clear cell sarcoma.

Kim YC, Vandersteen DP, Jung HG.

Am J Dermatopathol. 2005 Feb;27(1):51-5.

PMID:
15677980
20.

Supplemental Content

Support Center